Atai Beckley (ATAI) Common Equity (2020 - 2025)
Atai Beckley (ATAI) recorded Common Equity of $159.91 million in Q3 2025, up 9.3% from $146.32 million a year earlier and up 11.1% from the prior quarter.
Powered by 
Analysis
Atai Beckley (ATAI) Common Equity (2020 - 2025) Analysis & Trends
At the end of FY2024, Atai Beckley reported Common Equity of $116.55 million, down 52.3% from FY2023.
- Annual Common Equity has declined for three straight years, though with a four-year compound annual growth rate of 5.1% (FY2020 to FY2024).
- Across earlier years, Common Equity came in at $244.32 million in FY2023 (-8.1%), $265.77 million in FY2022 (-31.1%), $385.96 million in FY2021 (+304.7%) and $95.37 million in FY2020.
- The Q3 2025 figure is the highest quarterly Common Equity since Q2 2024.
- On a year-over-year basis, Common Equity rose in 1 of the last eight quarters, with an average decline of 21.5%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 304.7% in Q4 2021, against a decline of 52.3% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $143.93 million (Q2 2025), $152.27 million (Q1 2025) and $116.55 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Atai Beckley | 1.77 Bn | 1.77 Bn | - | 159.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 159.91 Mn |
| Jun 30, 2025 | 143.93 Mn |
| Mar 31, 2025 | 152.27 Mn |
| Dec 31, 2024 | 116.55 Mn |
| Sep 30, 2024 | 146.32 Mn |
| Jun 30, 2024 | 168.53 Mn |
| Mar 31, 2024 | 223.26 Mn |
| Dec 31, 2023 | 244.32 Mn |
| Sep 30, 2023 | 268.51 Mn |
| Jun 30, 2023 | 215.64 Mn |
| Mar 31, 2023 | 240.64 Mn |
| Dec 31, 2022 | 265.77 Mn |
| Sep 30, 2022 | 296.08 Mn |
| Jun 30, 2022 | 320.12 Mn |
| Mar 31, 2022 | 354.36 Mn |
| Dec 31, 2021 | 385.96 Mn |
| Sep 30, 2021 | 462.76 Mn |
| Jun 30, 2021 | 484.90 Mn |
| Dec 31, 2020 | 95.37 Mn |
API Access
Atai Beckley Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ATAI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ATAI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ATAI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();